Last update:

Overweight & Obesity news

Overweight & Obesity

Consuming more protein may protect patients taking anti-obesity drug from muscle loss

Women and older adults taking the anti-obesity drug semaglutide may be at higher risk for muscle loss, but higher protein intake may help prevent muscle loss in these patients, according to a small study being presented Saturday ...

Overweight & Obesity

Combination of obesity medication tirzepatide and menopause hormone therapy fuels weight loss

Using tirzepatide and menopause hormone therapy at the same time leads to increased weight loss in postmenopausal women with overweight or obesity compared to use of tirzepatide treatment alone, according to a study being ...

Health

Obesity linked to what's on local restaurant menus

For many years, health experts have been concerned about "food deserts," places where residents lack good nutritional options. Now, an MIT-led study of three major global cities uses a new, granular method to examine the ...

Overweight & Obesity

Obesity care: Why 'eat less, move more' advice is failing

For years, people living with obesity have been given the same basic advice: eat less, move more. But while this mantra may sound simple, it's not only ineffective for many, it can be deeply misleading and damaging.

Health

A bigger waist may increase the risk of dying for older women

Older women with larger waist circumference may be at a much greater risk of dying for any given BMI, according to international research, which monitored women over more than two decades. The study found that for post-menopausal ...

Health

Midlife weight loss linked to longer, healthier lives

Losing weight via lifestyle adjustments can deliver significant long-term health benefits, without the need for surgery or anti-obesity drugs. Alongside preventing diabetes, it can help ward off chronic conditions including ...

Health

The role of GLP-1 receptor agonists in the management of obesity

As Australia faces a turning point in obesity management, researchers from Monash University have contributed new insights into the rapidly evolving use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) such as Ozempic ...

Neuroscience

Weight loss linked to nerve cells in the brain

Semaglutide belongs to a group of drugs called GLP-1R agonists and has been shown to effectively reduce food intake and body weight. The drug is already well established as part of the treatment for obesity and type 2 diabetes, ...

Attention deficit disorders

Link between ADHD and obesity might depend on where you live

Attention-deficit/hyperactivity disorder (ADHD) might contribute to obesity by reducing physical activity—a relationship that can also be mediated by the features of the urban environment in which a person lives.